Free US stock insider buying and selling tracking with regulatory filing analysis for inside information on company health. We monitor corporate insider transactions because company officers often have the best understanding of their business prospects.
Crescent Capital BDC Inc. Common stock (CCAP) is trading at $12.37 as of April 2, 2026, posting a single-session gain of 0.90% amid muted moves across the broader business development company (BDC) sector. This analysis explores key technical levels for CCAP, recent market context shaping its performance, and potential scenarios for its price action in upcoming sessions, with no company-specific earnings data available to drive near-term positioning. CCAP, which focuses on private credit lending
Is momentum building in Crescent Cap (CCAP) Stock | Price at $12.37, Up 0.90% - Post Earnings
CCAP - Stock Analysis
4893 Comments
682 Likes
1
Aylene
Trusted Reader
2 hours ago
Really could’ve benefited from this.
👍 106
Reply
2
Trisden
Regular Reader
5 hours ago
I should’ve waited a bit longer before deciding.
👍 30
Reply
3
Karlyle
Influential Reader
1 day ago
This feels like something important just happened quietly.
👍 269
Reply
4
Tishika
Registered User
1 day ago
I don’t know why but this has main character energy.
👍 110
Reply
5
Chasidi
New Visitor
2 days ago
Trading activity suggests measured optimism among investors.
👍 133
Reply
Disclaimer: Not investment advice. For informational purposes only. Past performance does not guarantee future results. Trading involves substantial risk of loss.